Jaroszyński Andrzej, Jaroszyńska Anna, Dąbrowski Wojciech, Zaborowski Tomasz, Stepulak Andrzej, Iłżecki Marek, Zubilewicz Tomasz
Institute of Medical Sciences, Jan Kochanowski University, Kielce, Poland.
Department of Family Medicine, Medical University of Lublin, Lublin, Poland.
Arch Med Sci. 2018 Mar;14(2):257-264. doi: 10.5114/aoms.2017.65926. Epub 2017 Feb 22.
Atrial fibrillation (AF) is a highly prevalent arrhythmia in hemodialysis (HD) patients, and an HD session may be a trigger for AF episodes. An abnormal P-terminal force in lead V1 (PTFV1) may predict new-onset AF in HD patients. The aim of the study was to assess the influence of the HD process on PTFV1 and to evaluate possible factors influencing PTFV1 in a group of selected HD patients.
One hundred and fifty-three selected HD patients entered the study. Blood chemistry, electrocardiography, and impedance cardiography were evaluated before and after HD. Echocardiography was performed on the morning after dialysis. Abnormal PTFV1 was defined as PTFV1 > 40 mm × ms.
Abnormal PTFV1 was found in 35.3% of patients before dialysis and in 48.4% of patients after dialysis. The results of multiple regression analysis revealed that the independent predictors of pre-dialysis abnormal PTFV1 were: left atrial volume index ( = 0.002), left ventricular mass index ( = 0.014), and pre-dialysis thoracic fluid content ( = 0.021) values. The independent predictors of HD-induced abnormal PTFV1 values were larger differences between pre-dialysis and post-dialysis values of serum potassium ( < 0.001) and mean arterial pressure ( = 0.008).
Abnormal PTFV1 is prevalent in HD patients. The HD process adversely affects PTFV1 values. Pre-dialysis abnormal PTFV1 is mainly associated with structural heart abnormalities and hydration status. HD-induced abnormal PTFV1 is associated predominantly with serum potassium changes as well as HD-induced hypotension. Our results suggest possible risk factors for AF; however, their clinical significance needs to be confirmed in follow-up studies.
心房颤动(AF)在血液透析(HD)患者中是一种非常普遍的心律失常,一次HD治疗可能是房颤发作的诱因。V1导联P波终末电势(PTFV1)异常可能预测HD患者新发房颤。本研究的目的是评估HD过程对PTFV1的影响,并评估一组选定HD患者中影响PTFV1的可能因素。
153例选定的HD患者进入本研究。在HD前后评估血液化学、心电图和阻抗心动图。透析后次日上午进行超声心动图检查。PTFV1异常定义为PTFV1>40mm×ms。
透析前35.3%的患者PTFV1异常,透析后48.4%的患者PTFV1异常。多元回归分析结果显示,透析前PTFV1异常的独立预测因素为:左心房容积指数(=0.002)、左心室质量指数(=0.014)和透析前胸腔液体含量(=0.021)值。HD诱导的PTFV1异常值的独立预测因素是透析前和透析后血清钾值(<0.001)和平均动脉压(=0.008)之间的较大差异。
PTFV1异常在HD患者中普遍存在。HD过程对PTFV1值有不利影响。透析前PTFV1异常主要与心脏结构异常和水化状态有关。HD诱导的PTFV1异常主要与血清钾变化以及HD诱导的低血压有关。我们的结果提示了房颤的可能危险因素;然而,它们的临床意义需要在后续研究中得到证实。